WST Intrinsic Valuation and Fundamental Analysis - West Pharmaceutical Services Inc - Alpha Spread

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 312.28 USD 1% Market Closed
Market Cap: 23.1B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

Intrinsic Value

The intrinsic value of one WST stock under the Base Case scenario is 224.87 USD. Compared to the current market price of 312.28 USD, West Pharmaceutical Services Inc is Overvalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

WST Intrinsic Value
224.87 USD
Overvaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
West Pharmaceutical Services Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for WST cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about WST?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about West Pharmaceutical Services Inc

Provide an overview of the primary business activities
of West Pharmaceutical Services Inc.

What unique competitive advantages
does West Pharmaceutical Services Inc hold over its rivals?

What risks and challenges
does West Pharmaceutical Services Inc face in the near future?

Has there been any significant insider trading activity
in West Pharmaceutical Services Inc recently?

Summarize the latest earnings call
of West Pharmaceutical Services Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for West Pharmaceutical Services Inc.

Provide P/S
for West Pharmaceutical Services Inc.

Provide P/E
for West Pharmaceutical Services Inc.

Provide P/OCF
for West Pharmaceutical Services Inc.

Provide P/FCFE
for West Pharmaceutical Services Inc.

Provide P/B
for West Pharmaceutical Services Inc.

Provide EV/S
for West Pharmaceutical Services Inc.

Provide EV/GP
for West Pharmaceutical Services Inc.

Provide EV/EBITDA
for West Pharmaceutical Services Inc.

Provide EV/EBIT
for West Pharmaceutical Services Inc.

Provide EV/OCF
for West Pharmaceutical Services Inc.

Provide EV/FCFF
for West Pharmaceutical Services Inc.

Provide EV/IC
for West Pharmaceutical Services Inc.

Show me price targets
for West Pharmaceutical Services Inc made by professional analysts.

What are the Revenue projections
for West Pharmaceutical Services Inc?

How accurate were the past Revenue estimates
for West Pharmaceutical Services Inc?

What are the Net Income projections
for West Pharmaceutical Services Inc?

How accurate were the past Net Income estimates
for West Pharmaceutical Services Inc?

What are the EPS projections
for West Pharmaceutical Services Inc?

How accurate were the past EPS estimates
for West Pharmaceutical Services Inc?

What are the EBIT projections
for West Pharmaceutical Services Inc?

How accurate were the past EBIT estimates
for West Pharmaceutical Services Inc?

Compare the revenue forecasts
for West Pharmaceutical Services Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of West Pharmaceutical Services Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of West Pharmaceutical Services Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of West Pharmaceutical Services Inc compared to its peers.

Compare the P/E ratios
of West Pharmaceutical Services Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing West Pharmaceutical Services Inc with its peers.

Analyze the financial leverage
of West Pharmaceutical Services Inc compared to its main competitors.

Show all profitability ratios
for West Pharmaceutical Services Inc.

Provide ROE
for West Pharmaceutical Services Inc.

Provide ROA
for West Pharmaceutical Services Inc.

Provide ROIC
for West Pharmaceutical Services Inc.

Provide ROCE
for West Pharmaceutical Services Inc.

Provide Gross Margin
for West Pharmaceutical Services Inc.

Provide Operating Margin
for West Pharmaceutical Services Inc.

Provide Net Margin
for West Pharmaceutical Services Inc.

Provide FCF Margin
for West Pharmaceutical Services Inc.

Show all solvency ratios
for West Pharmaceutical Services Inc.

Provide D/E Ratio
for West Pharmaceutical Services Inc.

Provide D/A Ratio
for West Pharmaceutical Services Inc.

Provide Interest Coverage Ratio
for West Pharmaceutical Services Inc.

Provide Altman Z-Score Ratio
for West Pharmaceutical Services Inc.

Provide Quick Ratio
for West Pharmaceutical Services Inc.

Provide Current Ratio
for West Pharmaceutical Services Inc.

Provide Cash Ratio
for West Pharmaceutical Services Inc.

What is the historical Revenue growth
over the last 5 years for West Pharmaceutical Services Inc?

What is the historical Net Income growth
over the last 5 years for West Pharmaceutical Services Inc?

What is the current Free Cash Flow
of West Pharmaceutical Services Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for West Pharmaceutical Services Inc.

Business Breakdown

West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
West Pharmaceutical Services Inc

Current Assets 1.5B
Cash & Short-Term Investments 446.2m
Receivables 479.4m
Other Current Assets 557.4m
Non-Current Assets 2B
Long-Term Investments 198.2m
PP&E 1.6B
Intangibles 120.2m
Other Non-Current Assets 53m
Current Liabilities 633.7m
Accounts Payable 211.7m
Accrued Liabilities 103.2m
Other Current Liabilities 318.8m
Non-Current Liabilities 278.9m
Long-Term Debt 75.3m
Other Non-Current Liabilities 203.6m
Efficiency

Earnings Waterfall
West Pharmaceutical Services Inc

Revenue
2.9B USD
Cost of Revenue
-1.9B USD
Gross Profit
1B USD
Operating Expenses
-422.7m USD
Operating Income
604m USD
Other Expenses
-79.1m USD
Net Income
524.9m USD

Free Cash Flow Analysis
West Pharmaceutical Services Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The company faced a mid-single-digit decline in organic sales in Q2 2024, with net sales of $702.1 million, a 5.9% decrease driven by customer destocking. This impacted key product lines like Westar and Daikyo Crystal Zenith, leading to a 690 basis point drop in the gross profit margin for proprietary products. Despite these setbacks, the company expects better performance in the second half of 2024. The full-year sales guidance has been adjusted to $2.87 billion to $2.9 billion with an EPS range of $6.35 to $6.65. Capital expenditures for the year are projected at $375 million, up from previous estimates.

What is Earnings Call?
Fundamental Scores

WST Profitability Score
Profitability Due Diligence

West Pharmaceutical Services Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
62/100
Profitability
Score

West Pharmaceutical Services Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

WST Solvency Score
Solvency Due Diligence

West Pharmaceutical Services Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
83/100
Solvency
Score

West Pharmaceutical Services Inc's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WST Price Targets Summary
West Pharmaceutical Services Inc

Wall Street analysts forecast WST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WST is 360.25 USD with a low forecast of 267.65 USD and a high forecast of 493.5 USD.

Lowest
Price Target
267.65 USD
14% Downside
Average
Price Target
360.25 USD
15% Upside
Highest
Price Target
493.5 USD
58% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for WST?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for WST is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about WST dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

WST Price
West Pharmaceutical Services Inc

1M 1M
+4%
6M 6M
-21%
1Y 1Y
-20%
3Y 3Y
-29%
5Y 5Y
+120%
10Y 10Y
+628%
Annual Price Range
312.28
52w Low
276.9749
52w High
413
Price Metrics
Average Annual Return 25.98%
Standard Deviation of Annual Returns 59.57%
Max Drawdown -56%
Shares Statistics
Market Capitalization 22.7B USD
Shares Outstanding 74 000 000
Percentage of Shares Shorted 2.24%

Competitive Landscape

Ownership

WST Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

WST News

Other Videos

Profile

West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

22.7B USD

Dividend Yield

0.26%

Description

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,065 full-time employees. The firm operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Contact

PENNSYLVANIA
Exton
530 Herman O West Dr
+16105942900.0
www.westpharma.com

IPO

1923-07-27

Employees

10 065

Officers

See Also

Discover More
What is the Intrinsic Value of one WST stock?

The intrinsic value of one WST stock under the Base Case scenario is 224.87 USD.

Is WST stock undervalued or overvalued?

Compared to the current market price of 312.28 USD, West Pharmaceutical Services Inc is Overvalued by 28%.

Back to Top